益方生物(688382.SH)：向香港联合交易所递交H股发行上市申请并刊发申请资料

Group 1 - The company, Yifang Biotechnology (688382.SH), submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on January 1, 2026 [1] - The application materials were published on the Hong Kong Stock Exchange's website and are prepared in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] - The published materials are draft versions and may be updated or revised, indicating that investors should not make investment decisions based solely on this information [1]